Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients

Lorenzo Canti, Kevin K Ariën, Isabelle Desombere, Stéphanie Humblet-Baron, Pieter Pannus, Leo Heyndrickx, Aurélie Henry, Sophie Servais, Evelyne Willems, Grégory Ehx, Stanislas Goriely, Laurence Seidel, Johan Michiels, Betty Willems, Maria E Goossens, Yves Beguin, Arnaud Marchant, Frédéric Baron

Research output: Contribution to journalA1: Web of Science-articlepeer-review

19 Downloads (Pure)
Original languageEnglish
JournalCancer Cell
Issue number4
Pages (from-to)335-337
Number of pages3
Publication statusPublished - 2022


  • Antibody Formation
  • BNT162 Vaccine
  • COVID-19/prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination

Cite this